Category: atopic dermatitis

According to a recent study, patients with severe atopic dermatitis (AD) have higher rates of venous thromboembolism than those with moderate AD or without AD.

According to a recent study, patients with atopic dermatitis (AD) have a higher risk of non-melanoma skin cancers, such as squamous cell carcinoma and basal cell carcinoma, than those without AD.

According to a recent study, whether atopic dermatitis (AD) patients bathe weekly or daily has no impact on their symptoms.

According to a recent study, adults with atopic eczema are much more likely to experience suicidal thoughts than those without atopic eczema.

According to a recent study, investigators uncovered key risk factors for disease recurrence in moderate-to-severe atopic dermatitis (AD) patients after dupilumab discontinuation.

According to a recent study, lebrikizumab, a monoclonal antibody targeting IL-13, is effective in treating head and neck atopic dermatitis (AD) and erythema at 16 weeks of treatment.

According to a recent study, patients with more severe chronic hand eczema were willing to dedicate a substantial amount of time daily for treatment. 

In a recent study, researchers have identified specific risk factors for anxiety and depression in atopic dermatitis (AD) patients, including a lower education level and severe pruritus.

According to a recent study, ivarmacitinib, a Januse kinase (JAK)-1 inhibitor, has been shown to be effective and safe in treating adolescent and adult patients with atopic dermatitis (AD).

According to a recent study, patients with moderate-to-severe atopic dermatitis (AD) experience significant disease burden with physical, emotional, and social impact.